The FDA has introduced a comprehensive regulatory framework for AI and ML-enabled medical devices, emphasizing a streamlined approval process, the use of Predetermined Change Control Plans, and the importance of addressing algorithmic bias and transparency to ensure safety and effectiveness in healthcare technology.
The US government’s collaboration with OpenAI, involving agencies like NASA and the IRS, raises significant legal issues regarding data security and intellectual property rights, highlighted by a recent court ruling dismissing a copyright lawsuit against OpenAI and new policies in Delaware and Georgia addressing AI use in the judiciary.
Organizations must conduct Data Protection Impact Assessments (DPIAs) to manage privacy risks and ensure compliance with GDPR when processing high-risk data, particularly in the context of emerging technologies like AI.
JAMS Next has launched new arbitration rules tailored for AI-related disputes, addressing the complexities of AI systems and emphasizing expert involvement, confidentiality, and efficient resolution processes.
Major jurisdictions, including the EU, UK, US, and Singapore, are developing varied regulatory frameworks for AI, with the EU’s AI Act introducing a comprehensive risk-based approach, while the UK adopts a more flexible strategy, highlighting the need for organizations to navigate complex legal landscapes and ethical considerations in AI deployment.
The OECD will host the AI WIPS Conference in December 2024 to explore the implications of artificial intelligence on employment, productivity, and social policy, focusing on the necessary skills and training in the evolving labor market.
